News
Juvenile arthritis can impact more than just joints affecting eyes skin and internal organs Learn about its symptoms ...
The patient’s grade 4 bullous pemphigoid emerges despite cabozantinib dose reduction, requiring high-dose corticosteroids and ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results